Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma
Cancer cell(2018)
摘要
Hedgehog (Hh) pathway inhibitors such as vismodegib are highly effective for treating basal cell carcinoma (BCC); however, residual tumor cells frequently persist and regenerate the primary tumor upon drug discontinuation. Here, we show that BCCs are organized into two molecularly and functionally distinct compartments. Whereas interior Hh(+)/Notch(+) suprabasal cells undergo apoptosis in response to vismodegib, peripheral Hh(+++)/Notch(-) basal cells survive throughout treatment. Inhibiting Notch specifically promotes tumor persistence without causing drug resistance, while activating Notch is sufficient to regress already established lesions. Altogether, these findings suggest that the three-dimensional architecture of BCCs establishes a natural hierarchy of drug response in the tumor and that this hierarchy can be overcome, for better or worse, by modulating Notch.
更多查看译文
关键词
basal cell carcinoma,skin cancer,Hedgehog,Notch,vismodegib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要